Genomic-analysis-oriented drug repurposing in the search for novel antidepressants

HIGHLIGHTS

• who: Mohammad Hendra Setia Lesmana and colleagues from the School of Nursing, College of Nursing, Taipei Medical University, Taipei, Taiwan have published the research work: Genomic-Analysis-Oriented Drug Repurposing in the Search for Novel Antidepressants, in the Journal: Biomedicines 2022, 10, 1947. of 17/02/2022
• what: The authors aimed to identify drug repurposing candidates for depression treatment by adopting a genomic-analysis-based approach. A descriptive schematic of this study is presented in Figure 1. The authors propose that STAT6 can be considered as a potential biomarker for depression. Despite the fact that . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.